Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agentAnne-Julie Cloux, Aimable Nahimana, Dominique Aubry et al.|Oncotarget|2019Cited by 22
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplantsAimable Nahimana, Michel A. Duchosal, Antoine Attinger et al.|Blood Cancer Journal|2011Cited by 3